Home | Add Company | Subscribe | Search | Contact

BioPharmaLink

 

Login

Directory:

Add Company

Your company can benefit from enhanced listings. Questions? Read our FAQ first.

 

Personalized notification service and newsletter info

Subscribe (free) to get notified of new additions.

 

Learn more About us and about our Services

 

Contact us

Fenofibratum

Micronised capsules. Readily available Recent EU registration dossier

Offer available for: licensing

Pharmaceutical form and dosage: 200 mg / 67 mg Capsules


Type:

- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)


Therapeutic target:

- Cardiovascular

Action: Hypolipidaemics (CVS - X-Syndrome)

Company Contact


Corporate data: PharmaRegistrations
Belgium

Contact for this offer: Lieve Vermassen

Or check this company's:


Full Description:
Fenofibratum dossier:
-New readily available for licensing
-Marketing Authorization obtained in Belgium and France (we can also register in other countries)
-Form: Micronised capsules
-Stability: 25C: 36 months, 40C: 6 months


Availability and Market information:

Status: Registered (MA obtained)

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- Belgium : 2000
- United Kingdom
Registration info: On request: registration in other countries
BE available


Market information

Other Market Info:


Patent Information:
Name: Lipanthyl
Patent info: Expired


Suggestion box | Disclaimer | Privacy Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page Last modified: 15-Jan-2002.

Home | Add Company | Subscribe to Newsletter | Search Companies | Search Offers | Power search